Page 5 - Indian Pharma

Pharma majors join hands for Molnupiravir trial for Covid-19 treatment

Leading drug makers have decided to collaborate for clinical trial of the investigational oral antiviral drug Molnupiravir

Manufacturers look to boost capacity as govt enhances vaccination scope

Firms work to secure raw material locally as imports remain a challenge

Indian pharma exports grow at 18% to $24.44 billion in FY 21 from $20.58 bn

Pharma exports from India witnessed over 18 per cent growth to USD 24.44 billion during the last financial year against USD 20.58 billion in FY20

Best of BS Opinion: A change in direction, healing a weak regulator & more

Here's a selection of Business Standard opinion pieces for the day

Indian pharma firms go local seeking to end reliance on China

Disruption to supplies from China due to the Covid-19 pandemic was also a major factor

Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost

Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportunities

Indian exports show signs of revival, up 16.2% to $6.2 bn in Jan first week

Exports grew 16.22 per cent year-on-year to $6.21 billion in the first week of January, mainly driven by healthy growth in pharmaceuticals, and engineering sectors, reflecting signs of revival

V G Somani: The DCGI chief, a man known by his actions, 'not of words'

To the media, Somani may be a man of few words but among peers he's known for quick responses

It's raining billionaires in India's pharma and health care space

Created 7 billionaires in 2020; now 17 super-rich promoters in the sector with combined wealth of Rs 4.35 trillion

A shot at transparency

Approval to Covaxin raises many questions

Covishield to cost Rs 200/dose for first 100 mn doses to govt: Serum CEO

MRP for private market Rs 1,000/ dose; current licence does not allow export or sale in private market

Next Covid-19 vaccine challenge: Crossing the economic and patent barrier

India's proposed WTO waiver faces stiff opposition from the US and EU

The next online tonic: E-majors, corporate giants eye e-pharmacy business

Amazon, Reliance recently announced their foray into e-pharma sector

Torrent Pharma Q2 net up 27% despite dip in US and Brazil revenues

Firm's consolidated total revenue for the quarter, however, fell marginally by 0.7% to stand at Rs 2,023 crore

Best time to invest in pharma, medical device sector: Sadananda Gowda

This is the most opportune time to invest in the Indian pharma and medical device sector as the government is extending production linked incentives for new manufacturing units, Gowda has said

New launches in key categories to trigger AstraZeneca Pharma's growth

Higher share of patented products, scope for margin improvement and chronic portfolio are key positives

RIL picks majority stake in Netmeds: How it became 'India ki pharmacy'

Promoted by Dadha Pharma, Netmeds is one of the earliest players in online pharmacy having incorporated in 2015

Chemist body warns against Amazon's entry into online pharmacy space

The letter has also been addressed to Prime Minister Narendra Modi, Union Home Minister Amit Shah and other top ministers and government officials

China crisis, India scouting for APIs a shot in arm for sick pharma PSU

Govt is trying to reduce dependence on China for APIs and develop indigenous sources

Covid-19 crisis: Indian drug companies yet to get nod to market remdesivir

The USFDA granted remdesivir an emergency use authorization for the treatment of hospitalized patients with severe Covid-19